Abstract Post-Operative Cognitive Dysfunction (POCD) is a highly prevalent condition with
significant clinical, social and financial impacts for patients and their communities. The …

Ketamine is a noncompetitive antagonist of N-methyl-d-asparate (NMDA) receptor and has
been long used as an anesthetic agent in humans and veterinary medicine. The present …

Ketamine's clinical use began in the 1970s. Physicians benefited from its safety and ability to
induce short-term anesthesia and analgesia. The psychodysleptic effects caused by the …

Patients diagnosed with cancer often experience pain during their treatment course, making
it difficult to care for themselves and continue with their activities of daily living. When cancer …

Traumatic brain injury (TBI) is one of the most devastating forms of brain injury. Many
pathological mechanisms such as oxidative stress, apoptosis and inflammation all contribute …

Ketamine is a phencyclidine derivative that acts as a noncompetitive N-methyl-D-aspartate
as well as a glutamate receptor antagonist. It also has other minor mechanisms that …

Ketamine, a common N-methyl-d-aspartate receptor (NMDAR) antagonist, is an option for
cancer pain treatment in clinical practice. Ketamine has been shown to have the capacity to …

Ketamine drug was examined as an inhibitor of the corrosion of 316 stainless steel in 2MHCl
solution using weight loss, galvanostatic polarization, potentiodynamic anodic polarization …

Context Ketamine is a well-characterized anesthetic agent, and subanesthetic ketamine
possesses analgesic effects in both acute and chronic pain. Objectives A systematic review …

Managing cancer-related pain poses significant challenges, prompting research into
alternative approaches such as ketamine. This systematic review aims to analyze and …